Integrated Diagnostics Holdings plc (IDGXF) Research

Integrated Diagnostics Holdings plc (IDGXF) functions as a consumer-focused healthcare enterprise, primarily dedicated to providing a comprehensive array of medical diagnostic services for patients. Its extensive service portfolio encompasses approximately 2,000 distinct diagnostic examinations, spanning diverse fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company maintains an operational footprint across Egypt, Jordan, Sudan, and Nigeria. By December 30, 2021, its network had grown to encompass 452 branch laboratories. Established in 1979, the organization's main office is situated in Saint Helier, Jersey.

Market snapshot

Symbol
IDGXF
Price
$0.58
Day change
0.00%
Market cap
$16.6B
P/E ratio
13.19x
52-week range
0.32-0.6983
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Next earnings
in 2 months

Peer companies

  • Applied DNA Sciences, Inc. (APDN)
  • Biodesix, Inc. (BDSX)
  • bioAffinity Technologies, Inc. (BIAF)
  • bioAffinity Technologies, Inc. (BIAFW)
  • Genetic Technologies Limited (GENE)
  • Genetron Holdings Limited (GTH)
  • HTG Molecular Diagnostics, Inc. (HTGM)
  • Interpace Biosciences, Inc. (IDXG)

Open Integrated Diagnostics Holdings plc (IDGXF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.